Vincristine-induced allodynia in the rat
- 1 July 2001
- journal article
- Published by Wolters Kluwer Health in Pain
- Vol. 93 (1) , 69-76
- https://doi.org/10.1016/s0304-3959(01)00294-9
Abstract
The aims of this study were two-fold: first, to simplify the method for creating a recently described neuropathic pain model in the rat, and second, to evaluate the effects of a number of drugs with analgesic or antihyperalgesic properties, in this model. Continuous intravenous vincristine iKeywords
This publication has 27 references indexed in Scilit:
- Potent Analgesic Effects of GDNF in Neuropathic Pain StatesScience, 2000
- Pain related behaviour during vincristine-induced neuropathy in ratsNeuroReport, 1999
- NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomyProceedings of the National Academy of Sciences, 1998
- Vocal fold palsy following vinca alkaloid treatmentThe Journal of Laryngology & Otology, 1998
- Spinal pharmacology of tactile allodynia in diabetic ratsBritish Journal of Pharmacology, 1997
- Vincristine hyperalgesia in the rat: A model of painful vincristine neuropathy in humansNeuroscience, 1996
- A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neuronsNature, 1996
- Peripheral neurotoxicity of taxol in patients previously treated with cisplatinCancer, 1995
- The Use of Oral Mexiletine for the Treatment of Pain after Peripheral Nerve InjuryAnesthesiology, 1992
- MEXILETINE FOR TREATMENT OF CHRONIC PAINFUL DIABETIC NEUROPATHYThe Lancet, 1988